Business Segments Hubei Jumpcan Pharmaceutical Co., Ltd.
Equities
600566
CNE0000018X6
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.76 CNY | -0.48% |
|
+2.61% | +1.75% |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Clearing Heat and Detoxifying | 214.04Cr | 242.21Cr | 287.18Cr | 337.96Cr | 268.84Cr | |||||
Pediatrics | 103.79Cr | 170.06Cr | 242.54Cr | 274.09Cr | 225.37Cr | |||||
Digestive | 168.97Cr | 180.45Cr | 176.79Cr | 168.67Cr | 115.49Cr | |||||
Other | 64Cr | 78Cr | 83Cr | 71Cr | 80Cr | |||||
Breathing | 28Cr | 48Cr | 58Cr | 64Cr | 65Cr | |||||
Cardiovascular Type | 7.76Cr | 8.31Cr | 9.62Cr | 8.39Cr | 7.66Cr | |||||
Gynecology | 6.22Cr | 5.9Cr | 5.37Cr | 4.07Cr | 3.69Cr | |||||
Pharmaceutical Products | ||||||||||
Commercial | 22Cr | 28Cr | 35Cr | 36Cr | 34Cr | |||||
Industrial | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
China | 616.5Cr | 763.05Cr | 899.64Cr | 965.45Cr | 801.69Cr | |||||
Total Assets | 1.05TCr | 1.21TCr | 1.5TCr | 1.81TCr | 1.85TCr | |||||
Interest Expense | -3.3Cr | -3.49Cr | -3.04Cr | -1.76Cr | -2.73Cr | |||||
Income Tax Expense | 21Cr | 23Cr | 34Cr | 47Cr | 44Cr | |||||
D&A | 28Cr | 29Cr | 30Cr | 30Cr | 30Cr | |||||
CAPEX | -43Cr | -25Cr | -24Cr | -30Cr | -17Cr | |||||
Net Income | 127.72Cr | 171.92Cr | 217.08Cr | 282.28Cr | 253.16Cr | |||||
EBT | 148.35Cr | 195.04Cr | 250.79Cr | 329.71Cr | 297.82Cr | |||||
Operating Income | 146.9Cr | 193.28Cr | 242.35Cr | 325.81Cr | 286.29Cr |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition